Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.

doi:10.1007/s10897-014-9803-7

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Personalized Medicine Through SNP Testing for Breast Cancer Risk: Clinical Implementation.

Journal of genetic counseling - 1 Oct 2015

Howe Rebecca, Miron-Shatz Talya, Hanoch Yaniv, Omer Zehra B, O'Donoghue Cristina, Ozanne Elissa M

Abstract excerpt

Single nucleotide polymorphisms (SNPs) have the potential to improve personalized medicine in breast cancer care. As new SNPs are discovered, further enhancing risk classification, SNP testing may serve to complement family history and phenotypic risk factors when assessed in a clinical setting. SNP analysis is particularly relevant to high-risk women who may seek out such information to guide their...

Topics

Adult
Breast Neoplasms
Decision Making
Female
Genetic Predisposition to Disease
Genetic Testing
Humans
Middle Aged
Polymorphism, Single Nucleotide
Precision Medicine

Source

Open in PubMed

Identifiers

PMID: 25519004
DOI: 10.1007/s10897-014-9803-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics